Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

Bengt Jonsson, O. Strom, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson, John A. Kanis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)967-982
JournalOsteoporosis International
Volume22
Issue number3
DOIs
Publication statusPublished - Mar 2011

Keywords

  • Adherence
  • Compliance
  • Fracture
  • Model
  • Persistence
  • Sweden

Cite this

Jonsson, B., Strom, O., Eisman, J. A., Papaioannou, A., Siris, E. S., Tosteson, A., & Kanis, J. A. (2011). Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporosis International, 22(3), 967-982. https://doi.org/10.1007/s00198-010-1424-x